MX9709187A - Agentes contra protozoos parasitos. - Google Patents

Agentes contra protozoos parasitos.

Info

Publication number
MX9709187A
MX9709187A MX9709187A MX9709187A MX9709187A MX 9709187 A MX9709187 A MX 9709187A MX 9709187 A MX9709187 A MX 9709187A MX 9709187 A MX9709187 A MX 9709187A MX 9709187 A MX9709187 A MX 9709187A
Authority
MX
Mexico
Prior art keywords
agents
use against
against parasitic
parasitic protozoa
robenidine
Prior art date
Application number
MX9709187A
Other languages
English (en)
Other versions
MXPA97009187A (es
Inventor
Lutz Assmann
Bernd Baasner
Axel Haberkorn
Folker Lieb
Winfried Lunkenheimer
Norbert Lui
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MX9709187A publication Critical patent/MX9709187A/es
Publication of MXPA97009187A publication Critical patent/MXPA97009187A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La presente invencion se refiere a mezclas de 2-fluoralquil-benzimidazoles sustituidos y poliéteres antibioticos o agentes contra la coccidiosis obtenidos sintéticamente (por ejemplo: Amprolium, Toltrazuril, Robenidi, Halofuginon, Monensin, salinimicina) para la lucha contra los protozoos parasitarios en animales.
MXPA/A/1997/009187A 1995-05-31 1997-11-27 Agentes contra protozoos parasitos MXPA97009187A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19519821.2 1995-05-31
DE19519821A DE19519821A1 (de) 1995-05-31 1995-05-31 Mittel gegen parasitäre Protozoen
PCT/EP1996/002164 WO1996038140A1 (de) 1995-05-31 1996-05-20 Mittel gegen parasitäre protozoen

Publications (2)

Publication Number Publication Date
MX9709187A true MX9709187A (es) 1998-03-31
MXPA97009187A MXPA97009187A (es) 1998-10-15

Family

ID=

Also Published As

Publication number Publication date
KR100424610B1 (ko) 2004-07-27
TW403651B (en) 2000-09-01
HUP9802292A3 (en) 2001-04-28
JPH11505854A (ja) 1999-05-25
BR9608594A (pt) 1999-01-05
AR003421A1 (es) 1998-08-05
DE59610836D1 (de) 2004-01-08
ZA964415B (en) 1997-01-09
NO320712B1 (no) 2006-01-23
KR19990022045A (ko) 1999-03-25
NO975433L (no) 1998-01-20
AU694663B2 (en) 1998-07-23
PL323594A1 (en) 1998-04-14
CN1196485C (zh) 2005-04-13
BR9608594B1 (pt) 2010-07-27
AU5819396A (en) 1996-12-18
ATE254917T1 (de) 2003-12-15
CN1192682A (zh) 1998-09-09
SK159897A3 (en) 1998-09-09
WO1996038140A1 (de) 1996-12-05
ES2211962T3 (es) 2004-07-16
SK284508B6 (sk) 2005-05-05
PL185216B1 (pl) 2003-04-30
DE19519821A1 (de) 1996-12-05
CZ378997A3 (cs) 1998-03-18
HUP9802292A2 (hu) 1999-05-28
CZ290157B6 (cs) 2002-06-12
DK0828487T3 (da) 2004-04-05
US6034116A (en) 2000-03-07
NZ308526A (en) 1999-05-28
EP0828487B1 (de) 2003-11-26
EP0828487A1 (de) 1998-03-18
NO975433D0 (no) 1997-11-26

Similar Documents

Publication Publication Date Title
MX9803792A (es) Inhibidor de proteina cinasa c.
DE69716135D1 (en) In 6-position durch thio substituierte paclitaxele
MY123149A (en) Solid oral dosage forms of valsartan
NO931635L (no) Fremgangsmaate for fremstilling av kinazolin-derivater
CA2216535A1 (en) Protein kinase c inhibitors
MXPA04003668A (es) Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
ZA926456B (en) 1-substituted 1H-imidazo-(4,5-c)quinolin-4-amines.
SV1998000122A (es) Medicamentos ref. pu 3375/sv
MY131434A (en) Angiotensin ii antagonists
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
ES2091689T3 (es) Aplicacion de la carbamazepina y de la oxcarbazepina en el tratamiento de la enfermedad de parkinson y de los sindromes parkinsonianos.
IL137536A0 (en) Gastroprotected omeprazole microgranules, method for obtaining same and pharmaceutical preparations
AU1753699A (en) Application of vasopressin antagonists for treating disturbances or illnesses ofthe inner ear
AR003175A1 (es) Una composicion farmaceutica que comprende un portador farmaceuticamente aceptable y un agente quimioterapeutico y un triazol, dicha composicion farmaceutica , dicha composicion farmaceutica que comprend eun potenciador, uso de un agente quimioterapeutico y un 1h-1,2,4-triazol y uso de un potenciador y dicho triazol para tratar cancer, tumores o infecciones virales en mamiferos de sangre caliente
AR003421A1 (es) Mezclas de bencimidazoles sustituidos, un proceso para su preparacion y el uso de los mismos para preparar agentes contra protozoos parasitarios
AU9534398A (en) Novel pharmaceutical composition
CA2328280A1 (en) Thienopyrimidines
AU6469401A (en) Pharmaceutically active compounds and methods of use
EP0387802A3 (en) 5-substituted-1,4-dihydro-4-oxonaphthyridine-3-carboxylate antibacterial agents
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
BG102342A (en) Optical active derivative of phenylpyrimidine as an anlgesics
ZA97657B (en) Ligand directed enzyme prodrug therapy.
EP0821953A3 (en) Anticoccidial methods and feedstuffs
ZA97596B (en) Solid instant-release forms of administration and processes for their production
TR199800488T1 (xx) Diskinezi i�in 5-HT3 resept�r antagonistleri.